A deadly, Ebola-like virus called Marburg is currently causing an outbreak in Rwanda. The country declared an outbreak of ...
That course has changed slightly. On Tuesday, Maraganore launched a start-up, City Therapeutics, that builds on his 20-year ...
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
It’s Nobel Prize season—the time of year when scientists speculate who among them will receive one of the most coveted awards ...
The venture capital firm Atlas Venture is launching a start-up that aims to develop antisense oligonucleotides for a ...
Victor Ambros and Gary Ruvkunreceive prize for the discovery of microRNA and its role in post-transcriptional gene regulation ...
Though the topic seems mundane, Jensen tells Newscripts the science is broadly applicable—everyone gets paper cuts—and ...
As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...
The ability to alter complex molecules by a single atom at a time would be incredibly useful for medicinal chemistry—it would ...
With the government’s balance of power set to shift after November’s election, the implications for science are far from ...
In the 20th century, corporate powerhouses like Bell Labs and DuPont Central Research funded R&D from their balance sheets, creating a clear path for postdoctoral scientists to innovate beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback